Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Leber

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Analytical and Bioanalytical Chemistry|August 2, 2012
Characterization of perchlorate in a new frozen human urine standard reference materialLee L Yu, Jeffery M Jarrett, W Clay Davis, et al.
Biochemistry|December 6, 1994
Lysine 182 of endothelin B receptor modulates agonist selectivity and antagonist affinity: evidence for the overlap of peptide and non-peptide ligand binding sitesJ A Lee, J A Brinkmann, E D Longton, et al.
Bioorganic & Medicinal Chemistry Letters|January 31, 2009
Aminofurazans as potent inhibitors of AKT kinaseMeagan B Rouse, Mark A Seefeld, Jack D Leber, et al.
Journal of Radioanalytical and Nuclear Chemistry|August 25, 2015
Certification of Total Arsenic in Blood and Urine Standard Reference Materials by Radiochemical Neutron Activation Analysis and Inductively Coupled Plasma - Mass SpectrometryRick L Paul, W Clay Davis, Lee Yu, et al.
Cancer Research|April 3, 2008
Characterization of an Akt kinase inhibitor with potent pharmacodynamic and antitumor activityNelson Rhodes, Dirk A Heerding, Derek R Duckett, et al.
Journal of Medicinal Chemistry|September 20, 2008
Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinaseDirk A Heerding, Nelson Rhodes, Jack D Leber, et al.
Journal of Medicinal Chemistry|January 5, 2007
Discovery of aminofurazan-azabenzimidazoles as inhibitors of Rho-kinase with high kinase selectivity and antihypertensive activityRobert A Stavenger, Haifeng Cui, Sarah E Dowdell, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Analytical and Bioanalytical Chemistry|August 2, 2012
Characterization of perchlorate in a new frozen human urine standard reference materialLee L Yu, Jeffery M Jarrett, W Clay Davis, et al.
Biochemistry|December 6, 1994
Lysine 182 of endothelin B receptor modulates agonist selectivity and antagonist affinity: evidence for the overlap of peptide and non-peptide ligand binding sitesJ A Lee, J A Brinkmann, E D Longton, et al.
Bioorganic & Medicinal Chemistry Letters|January 31, 2009
Aminofurazans as potent inhibitors of AKT kinaseMeagan B Rouse, Mark A Seefeld, Jack D Leber, et al.
Journal of Radioanalytical and Nuclear Chemistry|August 25, 2015
Certification of Total Arsenic in Blood and Urine Standard Reference Materials by Radiochemical Neutron Activation Analysis and Inductively Coupled Plasma - Mass SpectrometryRick L Paul, W Clay Davis, Lee Yu, et al.
Cancer Research|April 3, 2008
Characterization of an Akt kinase inhibitor with potent pharmacodynamic and antitumor activityNelson Rhodes, Dirk A Heerding, Derek R Duckett, et al.
Journal of Medicinal Chemistry|September 20, 2008
Identification of 4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-3-piperidinylmethyl]oxy}-1H-imidazo[4,5-c]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a novel inhibitor of AKT kinaseDirk A Heerding, Nelson Rhodes, Jack D Leber, et al.
Journal of Medicinal Chemistry|January 5, 2007
Discovery of aminofurazan-azabenzimidazoles as inhibitors of Rho-kinase with high kinase selectivity and antihypertensive activityRobert A Stavenger, Haifeng Cui, Sarah E Dowdell, et al.
Pageof 3